Biotech Values

[Jonathan Robinson]

I do wonder why he did not do an issuance comprised of some selling shareholder shares (his) and new shares. That is done all the time. I guess he would have gotten less proceeds if done this way, and if that is the reason he did not do it this way, then he is worse than we think.

And Dew, this does happen all the time and given the massive trading volumes, this could easily have gotten away. The stock would likely have traded several points lower however.

Jon